Literature DB >> 19767509

Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.

Bethan Psaila1, Aleksandra Petrovic, Lemke K Page, Jill Menell, Matthew Schonholz, James B Bussel.   

Abstract

Intracranial hemorrhage (ICH) is a rare but devastating complication of childhood immune thrombocytopenia purpura (ITP). A survey of ICH from 1987 to 2000 identified cases of ICH in childhood ITP in the United States. Forty patients with ICH and 80 matched ITP control subjects were accrued. The estimated incidence of ICH was 0.19% to 0.78%. Platelet counts were less than 20 x 10(9)/L in 90% and less than 10 x 10(9)/L in 75% of children with ICH. Eighteen (45%) children developed ICH within 7 days of diagnosis of ITP; for 10 of these, ICH was the presenting feature of ITP. Twelve (30%) children had chronic ITP. Head trauma and hematuria were the most prominent features associated with ICH, identified in 33% and 22.5% of the patients with ICH and 1 and none of the controls (both P < .001). Bleeding beyond petechiae and ecchymoses was also linked to ICH. Mortality was 25%; a further 25% had neurologic sequelae. Strategies by which high-risk children could be identified were considered, and the costs of preventive combination treatment were estimated. Children with severe thrombocytopenia plus head trauma and/or hematuria appeared to be at particularly high risk of ICH. Aggressive treatment of these children may be appropriate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767509      PMCID: PMC2786288          DOI: 10.1182/blood-2009-04-215525

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  On the conservative management of acute immune thrombocytopenia in children.

Authors:  M D Tarantino
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

2.  Spontaneous intracranial hemorrhage in children with immune thrombocytopenic purpura.

Authors:  Laxman Singh Arya; Yogesh Jain; Sunil Narain; V P Choudhry; H P Pati
Journal:  Indian Pediatr       Date:  2002-05       Impact factor: 1.411

3.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

Review 4.  Refractory immune thrombocytopenic purpura: current strategies for investigation and management.

Authors:  Bethan Psaila; James B Bussel
Journal:  Br J Haematol       Date:  2008-10       Impact factor: 6.998

5.  Intracranial hemorrhage in children with immune thrombocytopenic purpura

Authors:  H Iyori; F Bessho; H Ookawa; S Konishi; A Shirahata; S Miyazaki; K Fujisawa; J Akatsuka
Journal:  Ann Hematol       Date:  2000-12       Impact factor: 3.673

6.  The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.

Authors:  R Dickerhoff; A von Ruecker
Journal:  J Pediatr       Date:  2000-11       Impact factor: 4.406

7.  Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany.

Authors:  A H Sutor; A Harms; K Kaufmehl
Journal:  Semin Thromb Hemost       Date:  2001-06       Impact factor: 4.180

8.  Intracranial hemorrhage in childhood immune thrombocytopenic purpura.

Authors:  Dharma R Choudhary; Rahul Naithani; M Mahapatra; Rajat Kumar; Pravas Mishra; Renu Saxena
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

9.  Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.

Authors:  Cindy E Neunert; George R Buchanan; Paul Imbach; Paula H B Bolton-Maggs; Carolyn M Bennett; Ellis J Neufeld; Sara K Vesely; Leah Adix; Victor S Blanchette; Thomas Kühne
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

10.  Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Authors:  David J Kuter; James B Bussel; Roger M Lyons; Vinod Pullarkat; Terry B Gernsheimer; Francis M Senecal; Louis M Aledort; James N George; Craig M Kessler; Miguel A Sanz; Howard A Liebman; Frank T Slovick; J Th M de Wolf; Emmanuelle Bourgeois; Troy H Guthrie; Adrian Newland; Jeffrey S Wasser; Solomon I Hamburg; Carlos Grande; François Lefrère; Alan Eli Lichtin; Michael D Tarantino; Howard R Terebelo; Jean-François Viallard; Francis J Cuevas; Ronald S Go; David H Henry; Robert L Redner; Lawrence Rice; Martin R Schipperus; D Matthew Guo; Janet L Nichol
Journal:  Lancet       Date:  2008-02-02       Impact factor: 79.321

View more
  40 in total

Review 1.  Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.

Authors:  Lisa J Toltl; Donald M Arnold
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

2.  Intracranial Haemorrhage in a Patient Diagnosed with Idiopathic Thrombocytopaenic Purpura and Diabetic Ketoacidosis.

Authors:  B Özkan; A Kaya; A Erdil; M I Turan; M Büyükavcı; H Tan
Journal:  West Indian Med J       Date:  2015-05-05       Impact factor: 0.171

3.  Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.

Authors:  Takaaki Hato; Naoki Shimada; Yoshiyuki Kurata; Masataka Kuwana; Kingo Fujimura; Hirokazu Kashiwagi; Toshiro Takafuta; Mitsuru Murata; Yoshiaki Tomiyama
Journal:  Blood Adv       Date:  2020-04-28

4.  Joint Effects of GWAS SNPs in Coagulation System Confer Risk to Hypertensive Intracerebral Hemorrhage.

Authors:  Yanyan Cao; Min Tian; Qin Fang; Zheng Wen; Wei Wang; Hu Ding; Dao Wen Wang
Journal:  Neuromolecular Med       Date:  2017-07-17       Impact factor: 3.843

5.  Successful management of refractory chronic immune thrombocytopenia with intracranial hemorrhage by emergency splenectomy.

Authors:  Sanjeev Kumar Sharma; Nitin Gupta; Tulika Seth; M Srinivas; Pravas Mishra; Manoranjan Mahapatra
Journal:  Indian J Pediatr       Date:  2011-07-15       Impact factor: 1.967

Review 6.  Pediatric ITP: is it different from adult ITP?

Authors:  Jenny M Despotovic; Amanda B Grimes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

7.  IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP.

Authors:  Manuel Carcao; Mariana Silva; Michele David; Robert J Klaassen; MacGregor Steele; Victoria Price; Cindy Wakefield; Lussia Kim; Derek Stephens; Victor S Blanchette
Journal:  Blood Adv       Date:  2020-04-14

8.  Newly diagnosed immune thrombocytopenia: update on diagnosis and management.

Authors:  Deepak Bansal; Aruna Rajendran; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2013-10-05       Impact factor: 1.967

9.  Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.

Authors:  Reut Gurion; Anita Siu; Aaron R Weiss; Margaret Masterson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

Review 10.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.